Market Overview

UPDATE: Wedbush Maintains Tempur-Pedic International at Neutral Following Sealy Deal

Share:
Related TPX
Earnings Scheduled For July 30, 2015
Keybanc: Tempur Sealy's Upside Continues On
Williams-Sonoma Offers New Collection from Rejuvenation (Zacks)

Wedbush reiterated its Neutral rating and $27 price target on Tempur-Pedic International (NYSE: TPX) following agreement to purchase Sealy (NYSE: ZZ).

Wedbush commented, "The acquisition should be accretive during the first year, and the company expects annual operating cost savings of $40 million by the third year. In addition to operational cost savings (primarily through purchasing and supply chain), Tempur-Pedic has been able to refinance Sealy's debt obligations for a much lower interest rate, and it expects to reduce the company's combined leverage to an optimal level within four to five years. … Many questions remain as to what level of integration the combined company will pursue, and how this may affect future financial results."

Tempur-Pedic International closed at $30.33 on Thursday.

Latest Ratings for TPX

DateFirmActionFromTo
Jul 2015Longbow ResearchMaintainsBuy
Jul 2015Stifel NicolausMaintainsBuy
Jul 2015Stifel NicolausMaintainsBuy

View More Analyst Ratings for TPX
View the Latest Analyst Ratings

Posted-In: WedbushAnalyst Color News Reiteration M&A Analyst Ratings

 

Related Articles (TPX + ZZ)

View Comments and Join the Discussion!

Get Benzinga's Newsletters